Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shizhen formula is a Traditional Chinese Medicine (TCM) herbal preparation developed by Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine. It is specifically indicated for the treatment of anal eczema, particularly the 'damp-heat' pattern according to TCM diagnostics. The formula is designed to alleviate symptoms such as pruritus and skin lesions by modulating inflammatory pathways, specifically reducing the levels of pro-inflammatory cytokines including interleukin-4 (IL-4), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). Clinical evaluation of the formula focuses on its efficacy in improving the Eczema Area and Severity Index (EASI) and the Dermatologic Quality of Life Index (DLQI) while monitoring for recurrence and side effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shizhen formula.